CV Sciences, Inc. (CVSI)
OTCQB OTCQB Primary Summary
CV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) Q1 2026 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) Q1 2026 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) Q4 2025 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) Q4 2025 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has CV Sciences, Inc. ever had a stock split?
CV Sciences, Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Joseph D. Dowling CEO | OTCQB Exchange | 126654102 CUSIP |
| US Country | 43 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
CV Sciences, Inc., established in San Diego, California, since its inception in 2010, stands as a significant player in the North American market for herbal supplements and hemp-based cannabidiol (CBD) products. Initially known as CannaVest Corp., the company underwent a name change to CV Sciences, Inc. in January 2016, reflecting its broader commitment to scientific innovation within the CBD industry. The company’s operations encompass the development, manufacturing, marketing, and sale of a variety of CBD-based products and it is also pioneering cannabinoids for potential medical use. It caters to various sectors of the health care market including nutraceuticals, beauty care, specialty foods, and pet products, distributing its offerings through a spectrum of channels including its own websites, select distributors, brick-and-mortar retailers, and certain e-tailers.
Products and Services
- PlusCBD: A flagship product line from CV Sciences that offers an extensive range of CBD-based health and wellness supplements. These products are designed to support overall well-being.
- ProCBD: Catered towards those seeking enhanced benefits from their CBD use, ProCBD products are formulated to target specific wellness goals and concerns, offering a potent alternative within the CBD market.
- HappyLane: This range focuses on delivering 0% THC CBD products, ensuring consumers can enjoy the benefits of CBD without the psychoactive effects of THC. HappyLane is marketed towards individuals conscious about THC intake but eager to explore CBD’s potential.
- PlusCBD Pet: Recognizing the growing demand for pet wellness solutions, CV Sciences extends its CBD expertise to our furry friends. PlusCBD Pet products are designed to offer pets the same quality of CBD support that humans enjoy.
- CVSI-007: Beyond their consumer products, CV Sciences is invested in developing cannabinoids for therapeutic purposes. CVSI-007 is one such endeavor, combining CBD and nicotine in an innovative formulation intended to treat smokeless tobacco use and addiction, marking the company’s foray into addressing global health challenges through cannabinoid solutions.
